Wenjuan Tang

718 citations
48 papers · 509 indexed · h-index 15
Topics
Liver Disease Diagnosis and Treatment (7 papers)MicroRNA in disease regulation (4 papers)Diet, Metabolism, and Disease (4 papers)
Journals
SHILAP Revista de lepidopterologíaFree Radical Biology and MedicineBiochemical Pharmacology

In The Last Decade

Wenjuan Tang

43 papers receiving 504 citations

Peers

Wenjuan Tang
Comparison fields: 5 of 94
  • Molecular Biology 205
  • Epidemiology 89
  • Cancer Research 81
  • Endocrinology, Diabetes and Metabolism 64
  • Oncology 60
Replace Chengxu Ma with:
Chengxu Ma China
Zirui Wan China
Kevin Chu Hong Kong
Jong‐Jae Park South Korea
Panpan Liu China
Naureen Fatima India
Mahta Mazaheri Iran
Wenjuan Tang relative to Chengxu Ma China Chengxu Ma's profile →
Citations per field
00.5×
Chengxu Ma · 1×
Citations per year

Countries citing papers authored by Wenjuan Tang

Since Specialization
Citations

This map shows the geographic impact of Wenjuan Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjuan Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjuan Tang more than expected).

Fields of papers citing papers by Wenjuan Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjuan Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjuan Tang. The network helps show where Wenjuan Tang may publish in the future.

Co-authorship network of co-authors of Wenjuan Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjuan Tang. A scholar is included among the top collaborators of Wenjuan Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjuan Tang. Wenjuan Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 28
3 8
4 3
5 4
6 6
7 2
8 14
9 13
10 7
11 10
12 26
13 1
14 16
15 7
16 28
17 2
18 1
19 17
20 25

About Wenjuan Tang

Wenjuan Tang is a scholar working on Leadership and Management, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 48 papers that have together received 509 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), MicroRNA in disease regulation (4 papers) and Diet, Metabolism, and Disease (4 papers). The work is most often cited by research in Cancer Research (81 citations), Endocrinology, Diabetes and Metabolism (64 citations) and Complementary and alternative medicine (26 citations). Wenjuan Tang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yan Bi, Dalong Zhu, Yingzhuan Zhan, Jinhai Tang, Ting Hong, Wen Lu, Jue Wang, Chéng Wáng, Di Xu and Hongdong Wang. Their work appears in journals such as SHILAP Revista de lepidopterología, Free Radical Biology and Medicine and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026